Smart science to improve lives™
Open search Basket 0 View basket

Explore our newest products

We are a world leader in pharmaceutical excipients, vaccine adjuvants and lipid delivery systems for human and veterinary applications. 

Find out more information on our newest products:

squalene image with blue wash over image

Sustainably sourced Squalene

Introducing our sustainably sourced Squalene, produced using cutting-edge technology that centres on synthetic biology, our pharmaceutical-grade squalene has superior purity and carries the same squalene benefits as shark-derived squalene.

Vaccine shown over map image

Sustainable saponins (2024)

As we look to become more nature positive, we’re proud to be able to offer our next-generation QS 21 and support global sustainability efforts. Our next-generation QS 21 is based on plant tissue culture, which makes the process more efficient and sustainably sourced.

Woman in lab looking at tray with purple wash over image

Introducing Virodex™

We’re introducing our new range of detergents specifically designed to support the key steps in your biomanufacturing processes. The Virodex™ range for viral inactivation and cell lysis is REACH-compliant, compendial, sustainable, and has been optimised for use in biomanufacturing of recombinant proteins, blood fractionation products, viral vectors, and more.

How we empower biologics delivery

Image of Croda Pharma innovating in a lab

Enabling breakthrough innovation

Dedicated to developing the next generation of excipients and delivery systems to empower biopharma
Female Croda Pharma employee formulating in lab

Access to specialist formulation support

Enabling over 250 on-going clinical projects targeting a range of therapeutic areas across biologics and small molecules
Croda Pharma employee in a lab

Focused scientific expertise

Leading the way with specialist knowledge and synthesis expertise in excipients, adjuvants and lipids

Explore recent blogs:

manufacturing pd

QbD Formulation Development

Formulation development is a pivotal stage in the life cycle of a therapeutic drug product, it can be the make or break of it. The goal of formulation development is to convert active substance (drug...

Read more
green washed depiction of an LNP

Targeted lipid nanoparticles in Nucleic Acid Delivery

Targeted lipid nanoparticles (tLNPs) enhance the precision and efficacy of delivering a variety of therapeutic agents including nucleic acids to specific tissues and cell populations, thereby...

Read more
Blue washed image of female in the lab

Croda joins CGT Catapult consortium to improve AAV formulation

The Cell and Gene Therapy Catapult (CGT Catapult) has established a cross-industry consortium to improve the understanding and process optimisation of adeno-associated virus (AAV) formulation.

Read more
man in a lab looking at results

Synthesis, characterisation and degradation of polysorbates in biopharmaceuticals

Polysorbates are essential in biologics delivery, serving as crucial emulsifiers and stabilisers for biopharmaceuticals. They enhance solubility, improve bioavailability, and protect proteins from...

Read more